Physician profile
Adam Michael Thomas
NPI 1992906648
$6,792.46
in general payments reported to CMS, 2019-2025
36 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,930 · 2020: $411 · 2021: $849 · 2022: $982 · 2023: $924 · 2024: $1,174 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $1,000.00 | 2019 | |
| Smith+Nephew, INC. | $932.58 | 2020-2024 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
| Paratek Pharmaceuticals, INC. | $664.34 | 2021-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $624.25 | 2024-2025 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $601.02 | 2019-2022 | |
| Nevro Corp. | $585.09 | 2022-2024 | Senza |
| Stryker Corporation | $439.38 | 2019-2025 | Prostep Mica, Variax, Viaflow |
| Melinta Therapeutics, LLC | $307.42 | 2019-2022 | |
| Medtronic, INC. | $245.82 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $158.79 | 2022-2023 | Dalvance |
| Amgen INC. | $155.13 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $139.94 | 2021-2024 | Puraply Antimicrobial, Nushield, Puraply |
| Wright Medical Technology, INC. | $106.15 | 2019 | |
| Depuy Synthes Sales INC. | $104.83 | 2021 | |
| Baudax Bio INC. | $100.00 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $90.90 | 2019 | |
| Biotissue Holdings INC. | $87.12 | 2024 | |
| Biopro, INC. | $64.64 | 2023 | |
| Djo, LLC | $45.44 | 2022 | |
| Orthofix Medical, INC. | $42.69 | 2022 | |
| Zimmer Biomet Holdings, INC. | $36.55 | 2021 | |
| Stability Biologics, LLC | $25.28 | 2022 | |
| Reprise Biomedical, INC. | $22.66 | 2024 | Miro3d |
| Boston Scientific Corporation | $20.43 | 2020 | |
| Paragon 28, INC. | $19.60 | 2022 | |
| Alfasigma USA, INC. | $19.59 | 2021 | |
| Inari Medical, INC. | $18.75 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kowa Pharmaceuticals America, INC. | $18.37 | 2023 | Seglentis |
| Nabriva Therapeutics, Plc | $18.27 | 2021 | |
| Sebela Pharmaceuticals INC. | $16.18 | 2023 | Pramosone, Naftin |
| Celularity INC. | $16.00 | 2019 | |
| Cdc Medical LLC | $15.71 | 2022 | |
| Pfizer INC. | $14.78 | 2019 | |
| Zyla Life Sciences, INC. | $13.75 | 2020 | |
| Dynasplint Systems INC. | $10.70 | 2020 | |
| Biocomposites INC | $10.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.